ELMSFORD, N.Y., June 19, 2015 /PRNewswire/ --
BioScrip®, Inc. (NASDAQ: BIOS) ("BioScrip"), today
announced that it has completed its exchange offer (the "Exchange
Offer") of $200,000,000 in
aggregate principal amount of 8.875% Senior Notes due 2021 (the
"Exchange Notes"), which have been registered under the Securities
Act of 1933, as amended (the "Securities Act"), for an equal
aggregate principal amount of its outstanding 8.875% Senior Notes
due 2021 (the "Old Notes") that were originally issued
on February 11, 2014, in a transaction exempt from
registration under the Securities Act.
As of the scheduled expiration time of 5:00 p.m., New York
City time, on June 16, 2015,
$200,000,000 of the aggregate
principal amount, or 100%, of the Old Notes were tendered and
accepted for exchange by BioScrip.
This press release is neither an offer to purchase, nor a
solicitation for acceptance of an offer to sell, any
securities. The Exchange Offer was made only by means of, and
pursuant to the terms of, the Prospectus, dated as of May 7, 2015 (the "Prospectus") and the related
Letter of Transmittal (the "Letter of Transmittal"). The
complete terms and conditions of the Exchange Offer are set forth
in the Prospectus and the Letter of Transmittal. Holders are
urged to read these documents carefully.
About BioScrip, Inc.
BioScrip, Inc. is a leading national provider of infusion
and home care management solutions. BioScrip partners
with physicians, hospital systems, skilled nursing facilities,
healthcare payors, and pharmaceutical manufacturers to provide
patients access to post-acute care
services. BioScrip operates with a commitment to bring
customer-focused pharmacy and related healthcare infusion therapy
services into the home or alternate-site setting. By collaborating
with the full spectrum of healthcare professionals and the
patient, BioScrip provides cost-effective care that is
driven by clinical excellence, customer service, and values that
promote positive outcomes and an enhanced quality of life for those
it serves. BioScrip provides its infusion services from
over 70 locations across 28 states.
Logo -
http://photos.prnewswire.com/prnh/20130117/NY44138LOGO
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/bioscrip-announces-completion-of-exchange-offer-for-its-8875-senior-notes-due-2021-300102153.html
SOURCE BioScrip, Inc.